Which pharmacologic agents are under investigation for the treatment of systemic lupus erythematosus (SLE)?

Updated: Aug 04, 2021
  • Author: Christie M Bartels, MD, MS; Chief Editor: Herbert S Diamond, MD  more...
  • Print
Answer

Pharmacologic agents targeting specific pathways such as cytokines and complement, as well as combinations of rituximab with costimulatory inhibition with anti-CD40L or CTLA-4Ig, may prove to be more effective in treating SLE. [135]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!